Shanghai Henlius Biotech, Inc. (2696.HK)
HKD 23.9
(0.21%)
HKD 23.9
(0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.39 Billion | 3.21 Billion | 1.68 Billion | 587.58 Million | 90.92 Million | 7.42 Million |
| Cost of Revenue | 1.47 Billion | 844.62 Million | 522.74 Million | 182.11 Million | 71.82 Million | 5.39 Million |
| Gross Profit | 3.91 Billion | 2.37 Billion | 1.15 Billion | 405.46 Million | 19.1 Million | 2.02 Million |
| Operating Expenses | 3.28 Billion | 2.72 Billion | 1.78 Billion | 1.29 Billion | 820.9 Million | 458.54 Million |
| Selling, General and Administrative Expenses | 2.16 Billion | 1.4 Billion | 800.86 Million | 436.28 Million | 220.52 Million | 39.2 Million |
| Research and Development Expenses | 1.11 Billion | 1.39 Billion | 1.02 Billion | 894.14 Million | 607.82 Million | 365.38 Million |
| Other Expenses | - | -69.04 Million | -41.89 Million | -35.39 Million | -7.44 Million | 64 Thousand |
| Cost and Expenses | 4.76 Billion | 3.57 Billion | 2.3 Billion | 1.47 Billion | 892.72 Million | 463.94 Million |
| Operating Income | 631.7 Million | -586.57 Million | -871.74 Million | -949.85 Million | -821.2 Million | -456.52 Million |
| Interest Expense | 110.53 Million | 105.67 Million | 84.82 Million | 43.7 Million | 48.3 Million | 57.89 Million |
| Income Tax Expense | 23.55 Million | 1.37 Million | 27.31 Million | 43.69 Million | 655 Thousand | 4.56 Million |
| Earnings before Tax | 569.57 Million | -693.88 Million | -956.73 Million | -993.54 Million | -874.81 Million | -500.22 Million |
| Net Income | 546.01 Million | -695.25 Million | -984.05 Million | -1.03 Billion | -875.46 Million | -493.68 Million |
| Earnings Per Share Basic | 1.00 | -1.28 | -1.83 | -1.96 | -1.76 | -0.95 |
| Earnings Per Share Diluted | 1.00 | -1.28 | -1.83 | -1.96 | -1.76 | -0.92 |
| Weighted Average Shares Outstanding | 546.01 Million | 542.02 Million | 537.73 Million | 528.47 Million | 497.15 Million | 520.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 543.37 Million | 542.02 Million | 538.83 Million | 529.57 Million | 497.15 Million | 539.12 Million |
| Gross Margin | 0.73 | 0.74 | 0.69 | 0.69 | 0.21 | 0.27 |
| EBIT Margin | 0.17 | -0.10 | -0.40 | -1.39 | -8.12 | -53.81 |
| Profit Margin | 0.10 | -0.22 | -0.58 | -1.77 | -9.63 | -66.53 |
| EBITDA | 911.33 Million | -310.61 Million | -671.74 Million | -814.06 Million | -744 Million | -399.35 Million |
| Earnings Before Tax Margin | 0.12 | -0.18 | -0.52 | -1.62 | -9.03 | -61.52 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.37 Billion | 1.37 Billion | 1.46 Billion | 5.39 Billion | 1.42 Billion | 1.25 Billion |
| Cost of Revenue | 377.7 Million | 377.7 Million | 347.59 Million | 1.47 Billion | 406.88 Million | 360.81 Million |
| Gross Profit | 995.34 Million | 995.34 Million | 1.11 Billion | 3.91 Billion | 1.02 Billion | 889.41 Million |
| Operating Expenses | 771.31 Million | 771.31 Million | 922.81 Million | 3.19 Billion | 794.19 Million | 741.76 Million |
| Selling, General and Administrative Expenses | 530.08 Million | 530.08 Million | 645.69 Million | - | 545.72 Million | 473.69 Million |
| Research and Development Expenses | 241.23 Million | 241.23 Million | 301.13 Million | - | 269.77 Million | 273.91 Million |
| Other Expenses | - | - | -2.54 Million | -18.12 Million | -4.95 Million | - |
| Cost and Expenses | 1.14 Billion | 1.14 Billion | 1.27 Billion | 4.67 Billion | 1.2 Billion | 1.1 Billion |
| Operating Income | 224.03 Million | 224.03 Million | 193.83 Million | 710.39 Million | 217.81 Million | 141.8 Million |
| Interest Expense | - | - | 27.99 Million | 110.53 Million | 28.46 Million | - |
| Income Tax Expense | 4.7 Million | 4.7 Million | 19.6 Million | 23.55 Million | 81.11 Million | 1.97 Million |
| Earnings before Tax | 197.85 Million | 197.85 Million | 157.82 Million | 569.57 Million | 167.81 Million | 121.96 Million |
| Net Income | 193.15 Million | 193.15 Million | 138.22 Million | 546.01 Million | 167.81 Million | 119.99 Million |
| Earnings Per Share Basic | 0.36 | 0.36 | 0.25 | - | 0.31 | 0.22 |
| Earnings Per Share Diluted | 0.36 | 0.36 | 0.25 | - | 0.31 | 0.22 |
| Weighted Average Shares Outstanding | 544.08 Million | 544.08 Million | 552.89 Million | 543.29 Million | 543.5 Million | 545.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 543.49 Million | 543.49 Million | 543.58 Million | 543.37 Million | 543.49 Million | 543.22 Million |
| Gross Margin | 0.72 | 0.72 | 0.76 | 0.73 | 0.71 | 0.71 |
| EBIT Margin | 0.21 | 0.21 | 0.21 | - | 0.21 | 0.16 |
| Profit Margin | 0.14 | 0.14 | 0.09 | 0.10 | 0.12 | 0.10 |
| EBITDA | 293.17 Million | 293.17 Million | 309.5 Million | - | 298.89 Million | 205.62 Million |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.13 | 0.13 | 0.15 | 0.11 |
REFINE
LRD
CSBBANK
QUIK
0A0L
NARRF